Interspecies Modeling and Prediction of Human Exenatide Pharmacokinetics

Towards a Better Prediction of Peak Concentration, Volume of Distribution and Half-Life after Oral Drug Administration in Man, Using Allometry

(2011) Vikash K. Sinha et al.   CLINICAL PHARMACOKINETICS

Subcutaneous Absorption of Monoclonal Antibodies: Role of Dose, Site of Injection, and Injection Volume on Rituximab Pharmacokinetics in Rats

(2011) Leonid Kagan et al.   PHARMACEUTICAL RESEARCH

Glucagon-Like Peptide-1 Receptor Agonists Activate Rodent Thyroid C-Cells Causing Calcitonin Release and C-Cell Proliferation

(2010) Lotte Bjerre Knudsen et al.   ENDOCRINOLOGY

Pharmacokinetic and Pharmacodynamic Modeling of Exendin-4 in Type 2 Diabetic Goto-Kakizaki Rats

(2010) W. Gao et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Interspecies Scaling of Receptor-Mediated Pharmacokinetics and Pharmacodynamics of Type I Interferons

(2010) Leonid Kagan et al.   PHARMACEUTICAL RESEARCH

Effects of exendin-4 on glucose tolerance, insulin secretion, and beta-cell proliferation depend on treatment dose, treatment duration and meal contents

(2009) Masayuki Arakawa et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Exenatide prevents fat-induced insulin resistance and raises adiponectin expression and plasma levels

(2008) L. Li et al.   DIABETES OBESITY & METABOLISM

Pharmacokinetics and pharmacodynamics of exenatide following alternate routes of administration

(2008) Bronislava R. Gedulin et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Single- and multiple-dose pharmacokinetics of exendin-4 in rhesus monkeys

(2007) G AI et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS